Medline Inc. (MDLN)

Market Cap	47.67B
Revenue (ttm)	29.94B +12.1%
Net Income	701.00M -45.3%
EPS	0.80 +998.4%
Shares Out	1.31B
PE Ratio	45.57
Forward PE	24.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,333,690
Open	35.62
Previous Close	35.74
Day's Range	35.41 - 36.38
52-Week Range	31.49 - 50.88
Beta	n/a
Analysts	Buy
Price Target	44.42 (+22.5%)
Earnings Date	Nov 4, 2026

About MDLN

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam g...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Dec 17, 2025
• Employees: 45,000
• Stock Exchange: Nasdaq
• Ticker Symbol: MDLN
• Website: https://www.medline.com

Financial Performance

In 2025, Medline's revenue was $28.43 billion, an increase of 11.47% compared to the previous year's $25.51 billion. Earnings were $1.16 billion, a decrease of -3.42%.

Analyst Summary

According to 27 analysts, the average rating for MDLN stock is "Buy." The 12-month stock price target is $44.42, which is an increase of 22.50% from the latest price.

Price Target

$44.42

(22.50% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 10, 2026

Data Sources Report a data error